2024 SPEAKER FACULTY

Adalynn Harris

President & Chief Executive Officer

Equity Bridge

Ahsan Arozullah

Senior Vice President & Head, Oncology Development

Astellas Innovation Management LLC

Alice Yam

Vice President, Drug Discovery

Sutro Biopharma

Alireza Tafazzol

Senior Scientist II, Oncology Bioinformatics

AbbVie

Allan Ader

Managing Director

SafeBridge Consultants

Amit Garg

Executive Director, Clinical Pharmacology Oncology

Pfizer

Andreas Pahl

Chief Executive Officer

Heidelberg Pharma

Anette Sommer

Head of Biochemistry

Synaffix

Anikó Pálfi

Director, Biochemistry & Cell Biology

Heidelberg Pharma

Barbara Valsasina

ADC Portfolio Head

Nerviano Medical Sciences

Bertrand Cottineau

R&D Group Head

Axplora

Bilal Piperdi

Vice President, Clinical Development Oncology

Gilead Sciences

Bowen Jiang

Senior Research Scientist I, Bio Formulation & Process Development

Exelixis

Caleb Lee

Executive Director

Daiichi Sankyo

Candice Wong

Senior Director, Engineering & External Process Development

Pfizer

Charles Morgan

Head, Regulatory CMC

Denali Therapeutics

Charley Wu

Managing Director

Panlabs Biologics

Christian Marsolais

Senior Vice President & Chief Medical Officer

Theratechnologies

Christian Rohlff

Chief Executive Officer

Oxford BioTherapeutics

Christina Vasalou

Director, Head of ADC Translational PKPD

AstraZeneca

Chung-Yi Wu

Chief Executive Officer

CHO PHARMA INC

Conor Barry PhD

Associate VP, Global Biologics Technical Lead

Piramal Pharma Solutions

Daniel Calarese

Director, Innovation & Strategy

Sutro Biopharma

David Bramhill

President & Founder

Bramhill Biological Consulting

David Huang

Director, Medicinal Chemistry

OBI Pharma

Dawn Spiller

Senior Director & Group Manager

AstraZeneca

Do-Hyun Nam

Professor, Department of Neurosurgery

Sungkyunkwan University School of Medicine

Dominik Schumacher

Co-Founder & Chief Executive Officer

Tubulis

Dowdy Jackson

Chief Executive Officer

Jackson Consulting Group

Edward Kavalerchik

Senior Medical Director

Genmab

Eleni Taoula

Account Manager

Beacon Targeted Therapeutics

Engin Ayturk

Senior Director, CMC Bioconjugation, Process Development & Manufacturing

Exelixis

Eric Vajda

Vice President, Preclinical R&D

OmniAb

Eshita Khera

Principal Scientist II

Novartis

Esohe Idusogie

Head, Process Quality & CMC Analytical

ADC Therapeutics

Flavia Storelli

Clinical Pharmacologist, Oncology Division

Pfizer

Forgivemore Magunda

Principal Pathologist

Pfizer

Francisco Velasquez

Senior Director, Chemistry

Abzena

Frank Comer

Director, Tumor Targeted Delivery, Early Oncology Discovery

AstraZeneca

Gail Lewis

Senior Principal Scientist

Genentech

Gang Yin

Vice President, Research

Sutro Biopharma

Gary Conway

Principal Production Scientist, GMP Manufacturing

MilliporeSigma

Geoff Winters

Associate Director & Functional Lead, ADC Process Development

Zymeworks

Gerhard Frey

Vice President, Technology Development

BioAtla

Gilles Gallant

Chief Development Officer

Mythic Therapeutics

Greg Thurber

Associate Professor & Chair, Graduate Education

University of Michigan

Haichuan Liu

Manager, Strategic Marketing, Protein Characterization

SCIEX

Hanna Wagner

Supervisor, Process Development Bioconjugates,

Lonza

Hans-Peter Gerber

Chief Scientific Officer

Sutro Biopharma

Harald Haeske

Chief Medical Officer

Oxford BioTherapeutics

Harshil Renawala

Senior Scientist, Sterile Drug Product Commercialization

Merck & Co

Heller Chen

Senior Clinical Pharmacologist II

Gilead Sciences

Hema Balachandra

Associate Director, Biologics CMC

Merck & Co

Hetal Sarvaiya

Director, QTAS (DMPK-BA)

AbbVie

Hua Fang

Scientific Director, Clinical Development Oncology

AbbVie

Jake Morris

Senior Account Manager & ADC Insights Lead

Beacon Targeted Therapeutics

James Palacino

Head, Research

Orum Therapeutics

Jason Reeves

Director, Application Science

Nucleai

Jay Harper

Director, Early Oncology

AstraZeneca

Jay Mettetal

Senior Director, Oncology Bioscience

AstraZeneca

Jeffery Liu

Chief Scientific Officer

Huadong Medicine

Jeffrey Settleman

Senior Vice President, Chief Scientific Officer, Oncology R&D

Pfizer

Jenny Hunt

Director, Corporate Alliances

Aureka Biotechnologies

Jian Chen

Director, Translational Research & Preclinical Development

BioAtla

Jinwon Jung

Senior Director, Protein Engineering

ABL Bio

Joanne Lim

Associate Director, Immunology

Orum Therapeutics

John Lambert

Independent Consultant & Honorary Professor

Queens University Belfast

John Stevens

Application Specialist, Small Molecules & ADCs

MilliporeSigma

John Vieceli

Chief Product Officer

Quantum-Si

John Woodgate

Senior Strategy Manager, Bioprocess

Cytiva

Jon Travers

Senior Director, External Innovation & Early Development

Ipsen

Jose Mejia Oneto

Founder & Chief Executive Officer

Shasqi

Joseph Jeong

Vice President, ADC Development Team

Samsung Biologics

Juhani Saarinen

Chief Executive Officer

Glykos Finland Oy

Julien Dugal-Tessier

President & Chief Scientific Officer

NJ Bio

Jun Hayashi

President

Precision Antibody

Jutta Deckert

Vice President, Research & Development

Iksuda Therapeutics

Kaijie He

Vice President, Cancer Biology & ADC

Innovent Biologics

Karina Zuck

Senior CMC Reviewer

FDA

Kevin Hamblett

Senior Director, ADC Biology

Pfizer

Krishna Bajjuri

Senior Director, Chemistry

Sutro Biopharma

L. Nathan Tumey

Associate Professor

Binghampton University

Labros Meimetis

Research Assistant Professor, Department of Radiology

University of Wisconsin

Lara McGrath

Director, Translational Medicine

AstraZeneca

Laura Kreckler

Senior Principal Research Scientist

AbbVie

Laurie Mlinar

Principal Research Scientist II

AbbVie

Ling He

Senior Director, Clinical Bioanalysis

Daiichi Sankyo

Linjie Han

Associate Director, Analytical Development, Operations S&T, Biologics

AbbVie

Lisa McDermott

Director, Process & Analytical Development

MilliporeSigma

Llorente Bonaga

Senior Director, Global Regulatory Affairs & Clinical Safety, CMC

Merck & Co

Marco Lobba

Co-founder & Chief Executive Officer

Catena Bio

Maria Elena Guadagno

Technical Operations & Business Executive Director

BSP Pharmaceuticals S.p.A

Marie Zhu

Chief Technology Officer

WuXi Biologics

Martin Steegmaier

Chief Scientific Officer

SOTIO Biotech

Martina McDermott

Adjunct Assistant Professor

UCLA

Mary Elmer

Executive Director, Patient Engagement Oncology

Merck & Co

Mary Jane Hinrichs

Senior Vice President, Global Head of Early Development

Ipsen Pharma

Melanie Derde

Head, Bioconjugation Operations

Axplora

Mike Schmidt

Chief Scientific Officer

Alloy Therapeutics

Mimi Zhu

Senior Manager, Downstream Process Development & Operations

GlaxoSmithKline

Mo Xu

Chief Medical Officer

Coherent Pharma

Musheng Bao

Vice President, Head of Biology

Nona Biosciences

Naresh Jain

Chief Executive Officer

NJ Bio, Inc.

Nicholas Willumsen

Director & Head, Oncology

Nordic Bioscience

Nicolas Agard

Senior Principal Scientist

Genentech

Nicole Swope

Senior Scientist, Analytical Sciences

AstraZeneca

Patrick Van Berkel

Chief Scientific Officer

ADC Therapeutics

Patrick Zweidler-McKay

Former Executive Medical Director

ImmunoGen

Paul Davis

President

Montgomery Holdings

Paul Jaminet

Chief Executive Officer

Angiex

Paul Marks

Product Specialist, TFF

Sartorius

Paul Song

Chief Scientific Officer

GeneQuantum Healthcare

Paul Thomas

Principal Research Scientist II, Biologics Analytical Research & Development

AbbVie

Paul Wolstenholme-Hogg

Vice President, Medicinal Chemistry

ADC Therapeutics

Petra Bennington

Director, Analytical Research & Development

Merck & Co

Philip Kuhl

Distinguished Scientist, Bioconjugation & Chemistry Commercialization

Merck & Co

Pierre Landais

Director, Commercial Development, Drug Product Services

Lonza

Pralay Mukhopadhyay

Vice President, Medicine Development Leader, Oncology R&D

GlaxoSmithKline Plc

Puja Sapra

Senior Vice President, Biologics Engineering & Oncology Targeted Discovery, Oncology R&D

AstraZeneca

Radhika Balasubramani

Director, Technical Product Steward, ADCs

Merck & Co

Rakesh Dixit

President & Chief Executive Officer

Bionavigen Oncology

Ricardo Zwirtes

Executive Director, Global Clinical Lead

Daiichi Sankyo, Inc.

Richard Klinghoffer

Senior Vice President, Head of Systems Biology

Tempus

Ricki Fairley

Chief Executive Officer & Co-Founder

TOUCH Black Breast Cancer Association

Robert Lutz

Chief Scientific Officer

Iksuda Therapeutics

Sang Jeon Chung

Chief Scientific Officer

AbTis

Sarah Kiehna

Director, Analytical Development & Quality Control

AbbVie

Sayumi Yamazoe

Associate Director

Bristol Myers Squibb

Scott Collins

Director, Non-Clinical Development

Mersana Therapeutics

Scott peterson

Head of ADC discovery

Pfizer

Seb Caille

Scientific Director, Process Development

Amgen

Shailee Patel

Scientific Liaison Analyst

Beacon Targeted Therapeutics

Shawn Zhang

Chief Scientific Officer

Ambrx, a Johnson & Johnson Company

Shelley Ackerman

Senior Director & Program Team Lead

Bolt Biotherapeutics

Shotaro Nagase

Researcher

Daiichi Sankyo

Shu-Hui Liu

Chief Scientific Officer

Multitude Therapeutics

Simon Jiang

Vice President, Biology

Lide Biotech

Simon Letarte

Director, Extended Structural Characterization

Gilead Sciences

Sonny Hsiao

Founder & Chief Executive Officer

Acepodia

Srinath Thirumalairajan

Director, Process Engineering

Pfizer

Stepan Chuprakov

Director of Chemistry

Catalent Pharma Solutions

Stephen Verespy

Scientific Leader

Abzena

Teresa Mako

Scientist I, Medicinal Chemistry

Orum Therapeutics

Thomas Nittoli

Senior Director

Regeneron

Tim Hagerty

PhD, Vice President, Life Science Strategy

Tempus

Timothy Lowinger

Chief Science & Technology Officer

Mersana Therapeutics

Tomohiro Fujii

ADC Researcher

Ajinomoto Bio-Pharma Services

Torsten Hechler

Senior Vice President, ADC Research

Heidelberg Pharma

Tracy Matray

Senior Director, R&D

Sony Biotechnology, a Second-Generation Subsidiary of Sony Corporation

Travis Biechele

Vice President, Research

Shasqi

Vikki Cerniglia

Senior Director, Biopharma Partnerships

Natera

Vikram Shenoy

Senior Scientist I, QTAS (DMPK-BA)

AbbVie

Vitor Sousa

Director, Business Development

Proveo

Wei Gong

CMC Operation General Manager

Aton Biotech

Wei Han Tan

Manager, Technical Sales & Customer Proposals, Drug Product Services

Lonza

Weibin Chen

Head of Analytical Chemistry

AsymBio

Weijun Li

Senior Director, Biologics Analytical Development & CMC Team Lead

Exelixis

William Sanders

Global Vice President, Chemical Development Operations

Veranova

Xiaoli Liao

Principal Scientist II, Operations S&T

AbbVie

Xiaona Jing

Senior Vice President, Global Product Development & Partnering

Multitude Therapeutics

Yajun Sun

Executive Director, Non-Clinical

GeneQuantum Healthcare

Yan Zhang

Senior Director, Translational Sciences

Eisai

Yang Qiu

Chief Scientific Officer

Duality Biologics

Yomadis Ortiz

Manager, Process and Analytical Development

Merck KGaA

Yosup Rew

Chief Technology Officer

IntoCell

Yu-Tzu Tsai

Associate Director, ADC & Translational Research

Oxford BioTherapeutics

Yuan Ren

Principal Scientist, Chemical Process Development, Analytical Chemistry

Bristol Myers Squibb

Yuanyuan Li

Director

Mersana Therapeutics

Yuhua Hu

Head, US-EU CMC Management

WuXi XDC

Yuting Huang

Senior Scientist & Group Leader

Pfizer

Zaiqi Wang

Chief Executive Officer

InxMed

Zhengqi Zhang

Senior Scientist

Merck & Co

Zhu Chen

Senior Vice President & Head, ADC Center of Excellence

Genmab

ADC SD Social Card (1)
2024 EVENT GUIDE
PARTNER
REGISTER INTEREST